Modulo Bio reposted this
I'm thrilled to announce that Modulo Bio has secured a $4.8M strategic investment from the Alzheimer's Drug Discovery Foundation (ADDF)! This funding will accelerate the development of our novel CSF1R inhibitor targeting Frontotemporal Dementia (FTD) and Amyotrophic Lateral Sclerosis (ALS). This investment is a powerful validation of our mission to reprogram the brain's immune system to combat neurodegenerative diseases. Our approach focuses on modulating microglial cells, the brain's primary immune cells, which play a crucial role in neuroinflammation and disease progression. This funding will support IND-enabling studies and bring our CSF1R inhibitor closer to clinical trials. I'm incredibly proud of our team's work and grateful for ADDF's belief in our vision to deliver new hope to patients with devastating neurodegenerative conditions.